DECARBONIZATION OF PHARMA MANUFACTURING:HOW TO MINIMIZE SCOPE 3 EMISSIONS

DECARBONIZATION OF PHARMA MANUFACTURING: HOW TO MINIMIZE SCOPE 3 EMISSIONS January 28, 2026, 2:00-3:30 PM GMT The largest share of the industry’s emissions is so-called Scope 3, indirect greenhouse gas emissions that occur all along the value chain. Scope 3 includes emissions produced from purchased goods and services, transportation and distribution (upstream), and the use and disposal of products (downstream). Companies are beginning to collaborate with suppliers, promote science-based targets, and develop new formulations. Join our webinar to learn from the experts: • What the business case is for managing Scope 3 emissions. • How Scope 3 emissions get measured and reduced. • How companies in emerging markets approach decarbonization, including Scope 3. • The experience of Granules India, an international manufacturer, with a commitment to reducing its Scope 3 emissions by 42% by 2030. Speakers: • Sadesh Sookraj, Global Decarbonization Advisor, IFC. • Mustafa Rangwala, Managing Director and Partner, Boston Consulting Group. • Miranda Hadfield, Managing Director and Partner, Boston Consulting Group. • Dr. Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India. Moderator: Isabelle Portebois Benjelloun, Global Lead Life Sciences, IFC. Language: English (Zoom and livestreamed on YouTube), Spanish (in Zoom only) Duration: 90 minutes Organized by the International Finance Corporation (IFC), a member of the World Bank Group, in partnership with the Government of Norway.